Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
Waisman Biomanufacturing and Waisman affiliate investigators Randolph Ashton and Krishanu Saha will be part of a new engineering research center that will develop transformative tools and technologies for the consistent, scalable and low-cost production of high-quality living therapeutic cells. Such cells could be used in a broad range of life-saving medical therapies now emerging from …
Stem cells are remarkable cells that have the ability to become almost any kind of specialized cells in our bodies. Given this extraordinary potential, how does a stem cell keep from having an identity crisis? A recent study from Waisman Center researcher Xinyu Zhao’s lab shows how a gene called MBD1 plays an important role …
Leaders of the University of Wisconsin–Madison lab that first transformed human stem cells into brain cells have started a company that produces and sells specialized neurons to drug researchers. BrainXell develops neurons from stem cells in its Madison lab, then freezes them for shipment. Once thawed in the customer’s lab, the cells undergo a final …
What do Night Owl Support Systems, the Trace Center, the Center for Healthy Minds, and Stratatech all have in common? The Waisman Center at the University of Wisconsin-Madison. Over the years, the Waisman Center has catalyzed the inception or growth of many unique programs. Several of these have developed into independent centers or companies with …
Waisman Center researchers Anita Bhattacharyya and Xinyu Zhao are looking to make stem cells glow. That glow will tell them that they have successfully turned on a gene that is usually turned off in individuals with fragile X syndrome. Turning on this gene – called FMR1 – could be an important way to treat this …
In their photographs, Jenni and Kyle Geurkink look like happy, healthy children. Jenni has a captivating smile and a twinkle in her eyes. Kyle is a sturdy toddler who loves brooms, mops and any occasion to laugh. First Christmases, first birthdays, first playtimes with cousins—these are just a few of the images of Jenni and …
Several research and infrastructure projects featuring Waisman Center researchers as the primary or co-investigator have been selected for the second round of funding through the UW2020
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
A University of Wisconsin-Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse—in mice—damage from the mutation that causes the syndrome.
An innovative project led by Waisman Center researchers Anita Bhattacharyya and Su-Chun Zhang is one of fourteen research initiatives that have been chosen for the first round of funding by the University of Wisconsin-Madison Office of the Vice Chancellor for Research and Graduate Education for the UW2020: WARF Discovery Initiative.
